BDSX
Price
$0.42
Change
+$0.02 (+5.00%)
Updated
Aug 11, 12:08 PM (EDT)
Capitalization
58.7M
81 days until earnings call
FLMNY
Price
$12.86
Change
+$0.34 (+2.72%)
Updated
Aug 5 closing price
Capitalization
5.47B
Interact to see
Advertisement

BDSX vs FLMNY

Header iconBDSX vs FLMNY Comparison
Open Charts BDSX vs FLMNYBanner chart's image
Biodesix
Price$0.42
Change+$0.02 (+5.00%)
Volume$200
Capitalization58.7M
Fielmann Group AG
Price$12.86
Change+$0.34 (+2.72%)
Volume$191
Capitalization5.47B
BDSX vs FLMNY Comparison Chart in %
Loading...
BDSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FLMNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BDSX vs. FLMNY commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDSX is a Hold and FLMNY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (BDSX: $0.40 vs. FLMNY: $12.86)
Brand notoriety: BDSX and FLMNY are both not notable
BDSX represents the Medical Specialties, while FLMNY is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BDSX: 76% vs. FLMNY: 28%
Market capitalization -- BDSX: $58.7M vs. FLMNY: $5.47B
BDSX [@Medical Specialties] is valued at $58.7M. FLMNY’s [@Pharmaceuticals: Other] market capitalization is $5.47B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $168.51B to $0. The average market capitalization across the [@Medical Specialties] industry is $9.89B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDSX’s FA Score shows that 0 FA rating(s) are green whileFLMNY’s FA Score has 1 green FA rating(s).

  • BDSX’s FA Score: 0 green, 5 red.
  • FLMNY’s FA Score: 1 green, 4 red.
According to our system of comparison, FLMNY is a better buy in the long-term than BDSX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDSX’s TA Score shows that 4 TA indicator(s) are bullish while FLMNY’s TA Score has 4 bullish TA indicator(s).

  • BDSX’s TA Score: 4 bullish, 5 bearish.
  • FLMNY’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, FLMNY is a better buy in the short-term than BDSX.

Price Growth

BDSX (@Medical Specialties) experienced а +10.27% price change this week, while FLMNY (@Pharmaceuticals: Other) price change was +2.72% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.25%. For the same industry, the average monthly price growth was +1.87%, and the average quarterly price growth was -1.45%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.86%. For the same industry, the average monthly price growth was -3.35%, and the average quarterly price growth was +2.88%.

Reported Earning Dates

BDSX is expected to report earnings on Oct 31, 2025.

Industries' Descriptions

@Medical Specialties (+4.25% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (+1.86% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FLMNY($5.47B) has a higher market cap than BDSX($58.7M). FLMNY YTD gains are higher at: 52.066 vs. BDSX (-73.824).
BDSXFLMNYBDSX / FLMNY
Capitalization58.7M5.47B1%
EBITDA-27.47MN/A-
Gain YTD-73.82452.066-142%
P/E RatioN/A28.42-
Revenue74.5MN/A-
Total Cash17.6MN/A-
Total Debt62.3MN/A-
FUNDAMENTALS RATINGS
FLMNY: Fundamental Ratings
FLMNY
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
90
SMR RATING
1..100
60
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
46
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BDSXFLMNY
RSI
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
20%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
24%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
32%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
23%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
21%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
25%
Advances
ODDS (%)
Bullish Trend 20 days ago
82%
Bullish Trend 29 days ago
50%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 5 days ago
26%
View a ticker or compare two or three
Interact to see
Advertisement
BDSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FLMNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AHKSF7.500.53
+7.60%
Asahi Kaisei Corp.
NSYC450.0010.00
+2.27%
National Stock Yards Co.
QNCCF0.890.01
+0.78%
Quantum eMotion Corp.
PRKWF3.14N/A
N/A
Parkway Life REIT
CNPWM33.50N/A
N/A
Connecticut Light & Power Co. (The)

BDSX and

Correlation & Price change

A.I.dvisor tells us that BDSX and ELMD have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BDSX and ELMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDSX
1D Price
Change %
BDSX100%
-10.40%
ELMD - BDSX
31%
Poorly correlated
-0.05%
PLSE - BDSX
26%
Poorly correlated
-0.07%
WRBY - BDSX
24%
Poorly correlated
-0.64%
MYGN - BDSX
24%
Poorly correlated
+3.61%
SMTI - BDSX
24%
Poorly correlated
+1.81%
More

FLMNY and

Correlation & Price change

A.I.dvisor tells us that FLMNY and AORT have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FLMNY and AORT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FLMNY
1D Price
Change %
FLMNY100%
N/A
AORT - FLMNY
24%
Poorly correlated
+25.23%
BDSX - FLMNY
23%
Poorly correlated
-10.40%
MODD - FLMNY
8%
Poorly correlated
+2.03%
SOAGY - FLMNY
7%
Poorly correlated
+1.10%
SHC - FLMNY
3%
Poorly correlated
+24.51%
More